MétaCan
Menu
Back to cohort

Clopidogrel Pharmacogenetics

2019· review· en· W2936489929 on OpenAlexafffund
Naveen L. Pereira, Charanjit S. Rihal, Derek So, Yves Rosenberg, Ryan J. Lennon, Verghese Mathew, Shaun G. Goodman, Richard M. Weinshilboum, Liewei Wang, Linnea M. Baudhuin, Amir Lerman, Ahmed Hasan, Erin Iturriaga, Yi-Ping Fu, Nancy L. Geller, Kent R. Bailey, Michael E. Farkouh

Bibliographic record

VenueCirculation Cardiovascular Interventions · 2019
Typereview
Languageen
FieldMedicine
TopicAntiplatelet Therapy and Cardiovascular Diseases
Canadian institutionsTed Rogers Centre for Heart ResearchSt. Michael's HospitalUniversity of Ottawa
FundersNational Heart, Lung, and Blood InstituteUniversity of California, San FranciscoSharp HealthCareUniversity of MinnesotaAurora Research InstituteMinneapolis Heart Institute FoundationKonyang UniversityChung-Ang UniversityYork UniversityAjou UniversityHenry Ford Health SystemGreenville Health SystemNorthShore University HealthSystemMinneapolis Heart InstituteChonnam National UniversityNYU Langone Medical CenterUniversity of California
KeywordsClopidogrelMedicinePercutaneous coronary interventionCYP2C19Conventional PCIInternal medicinePharmacogeneticsCardiologyPrasugrelAcute coronary syndromeGenotypingIntensive care medicineAspirinGenotypeMyocardial infarctionGenetics

Abstract

fetched live from OpenAlex

Common genetic variation in CYP2C19 (cytochrome P450, family 2, subfamily C, polypeptide 19) *2 and *3 alleles leads to a loss of functional protein, and carriers of these loss-of-function alleles when treated with clopidogrel have significantly reduced clopidogrel active metabolite levels and high on-treatment platelet reactivity resulting in increased risk of major adverse cardiovascular events, especially after percutaneous coronary intervention. The Food and Drug Administration has issued a black box warning advising practitioners to consider alternative treatment in CYP2C19 poor metabolizers who might receive clopidogrel and to identify such patients by genotyping. However, routine clinical use of genotyping for CYP2C19 loss-of-function alleles in patients undergoing percutaneous coronary intervention is not recommended by clinical guidelines because of lack of prospective evidence. To address this critical gap, TAILOR-PCI (Tailored Antiplatelet Initiation to Lessen Outcomes due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention) is a large, pragmatic, randomized trial comparing point-of-care genotype-guided antiplatelet therapy with routine care to determine whether identifying CYP2C19 loss-of-function allele patients prospectively and prescribing alternative antiplatelet therapy is beneficial.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.007
Threshold uncertainty score0.022

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0020.002
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0070.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.219
GPT teacher head0.420
Teacher spread0.202 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations221
Published2019
Admission routes2
Has abstractyes

Explore more

Same venueCirculation Cardiovascular InterventionsSame topicAntiplatelet Therapy and Cardiovascular DiseasesFrench-language works237,207